Cuomebio is a company based on R&D.
We have started before any others in research of good strain, and as a result, completed developing Cuome Q1, high concentration heat-killed probiotics series.
We satisfy both of consumers and manufacturers by world’s highest concentration and outstanding safety.
We strive more deeply in our R&D to improve safety & effectiveness, and input best efforts in developing the new concept of immunity modifier.
Cuombio Chief Researcher Wan-Jae Kim, Ph.D